Apollo Hospitals reported a 52% year-on-year increase in consolidated profit after tax, reaching ₹372 crore in Q3, while revenue grew by 14% to ₹5,527 crore. The company plans to add 1,400 beds starting in FY26, with significant growth in inpatient volumes in specialties such as oncology and cardiology contributing to increased revenue. Senior management indicated that the focus will be on enhancing high complexity care and specialty services to boost revenue.
Apollo, which operates 45 hospitals nationwide, aims to operationalize the new beds over the next two years, concentrating on expanding its presence in key metropolitan areas. In Q3 of FY25, high complexity care volumes doubled compared to overall growth, positively impacting average revenue per operating bed (ARPOB), which rose 8% year-on-year to ₹60,839. High complexity care includes treatments requiring intensive care and advanced medical expertise, with Apollo investing in services like CAR-T cell therapy, proton beam therapies, minimally invasive brain surgeries, and robotic cardiac surgery.
The hospital chain plans to enhance volumes in specialty segments such as cardiac, oncology, neurology, gastroenterology, and orthopedics, which saw a 10.3% increase in inpatient volume in Q3, compared to an overall growth of 5.3%. Inpatient revenue contributions from these segments included 10% from orthopedics, 10% from neurology, 6% from gastroenterology, 17% from oncology, and 18% from cardiology.
Apollo Hospitals intends to commission 1,400 beds across six facilities in FY26, targeting locations in the National Capital Region, Hyderabad, Kolkata, and Pune. As of December 31, the network had 7,996 operating beds and is on track to achieve its goal of adding 3,512 beds over the next three to four years, with additional expansions planned for cities like Mumbai, Varanasi, and Lucknow. The company will focus on growth in six core metropolitan areas.
